WealthCollab’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.7K Sell
259
-66
-20% -$5.78K 0.01% 374
2026
Q1
$27.7K Buy
325
+36
+12% +$3.21K 0.01% 300
2025
Q4
$22.8K Sell
289
-77
-21% -$6.04K 0.01% 360
2025
Q3
$29.3K Hold
366
0.01% 286
2025
Q2
$33.3K Sell
366
-40
-10% -$3.65K 0.02% 231
2025
Q1
$38K Buy
406
+75
+23% +$6.72K 0.02% 200
2024
Q4
$30.1K Sell
331
-18
-5% -$1.72K 0.02% 236
2024
Q3
$36.2K Buy
349
+18
+5% +$1.83K 0.02% 203
2024
Q2
$32.1K Buy
331
+14
+4% +$1.29K 0.02% 206
2024
Q1
$28.5K Buy
317
+18
+6% +$1.52K 0.02% 237
2023
Q4
$23.8K Buy
+299
New +$22.5K 0.02% 244

Other funds holding CL

WealthCollab's CL Position: Q2 2026 in Review

WealthCollab reduced its Colgate-Palmolive (CL) stake by 20% in Q2 2026, selling an estimated $5.78K and leaving 259 shares worth $23.7K. The position accounts for 0.01% of the portfolio, ranked #374.

WealthCollab first reported a position in CL in Q4 2023 and has held it in 11 quarters since. The position peaked at $38K in Q1 2025. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • WealthCollab held 259 shares of Colgate-Palmolive worth $23.7K as of Q2 2026.
  • WealthCollab sold 66 Colgate-Palmolive shares in Q2 2026, an estimated $5.78K.
  • Colgate-Palmolive made up 0.01% of WealthCollab's portfolio in Q2 2026, its #374 holding.
  • WealthCollab first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 11 quarters since.
  • WealthCollab's Colgate-Palmolive position peaked at $38K in Q1 2025.
  • 2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.